# FDA Inspection 636493 - Aurobindo Pharma Limited - October 13, 2009

Source: https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-limited/68cd681c-fb9d-4d3c-99bd-d99b1eb05aba/
Source feed: FDA_Inspections

> FDA Inspection 636493 for Aurobindo Pharma Limited on October 13, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 636493
- Company Name: Aurobindo Pharma Limited
- Inspection Date: 2009-10-13
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1304312 - 2026-02-10](https://www.globalkeysolutions.net/api/records/fda_inspections/aurobindo-pharma-limited/f603cc93-dc47-4606-8cf0-0dde6af906da/)
- [FDA Inspection 1169446 - 2022-05-10](https://www.globalkeysolutions.net/api/records/fda_inspections/aurobindo-pharma-limited/b9201ac7-5ec4-46dd-8aaf-7304c3c93094/)
- [FDA Inspection 1105823 - 2019-09-27](https://www.globalkeysolutions.net/api/records/fda_inspections/aurobindo-pharma-limited/65ccbba1-8a36-41aa-99c4-64321edccdd9/)
- [FDA Inspection 1022788 - 2017-06-24](https://www.globalkeysolutions.net/api/records/fda_inspections/aurobindo-pharma-limited/8d9ab63f-c6f2-4237-89f8-eb13c0866d60/)
- [FDA Inspection 927596 - 2015-03-13](https://www.globalkeysolutions.net/api/records/fda_inspections/aurobindo-pharma-limited/6c7e4565-5d73-4395-b181-5abaff503b71/)

Company: https://www.globalkeysolutions.net/companies/aurobindo-pharma-limited/95bcc3b3-09a1-4249-af2f-5c83de789b76

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c